HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical characteristics of laryngeal cancer in BRCA-1 mutation carriers.

AbstractBACKGROUND:
The aim of this study was to analyze the occurrence of clinical features characteristic of breast cancer type 1 susceptibility protein (BRCA-1)-dependent tumors in a series of BRCA-1 mutation carriers with laryngeal cancer.
PATIENTS AND METHODS:
The clinical features of five laryngeal cancer patients with BRCA-1 mutations registered in our center were analyzed for: sex, age at diagnosis, age at operation, tumor size and localization, histopathological subtype and grading, lymph node and distant metastases, mode of treatment and long term results of the therapy.
RESULTS:
The five patients were all men, with an average age at diagnosis of 52.4 years. The majority of the patients had clinical features typical of BRCA-1-dependent tumors: four out of the five patients had advanced staging at the time of diagnosis and in three of them the disorder disseminated within one year of follow-up.
CONCLUSION:
Since laryngeal carcinomas in men with BRCA-1 mutations show clinical features characteristic of BRCA-1 dependent tumors, it is reasonable to consider treatment modifications appropriate for this sub-group of tumors.
AuthorsEwa Jaworowska, Czesława Tarnowska, Jakub Lubiński, Pablo Serrano-Fernández, Tomasz Huzarski, Bogdan Górski, Bartlomiej Masojć, Jerzy Jakubiszyn, Aleksandra Korytowska, Andrzej Kram, Jerzy Rabczynski, Jan Lubiński
JournalAnticancer research (Anticancer Res) Vol. 29 Issue 7 Pg. 2703-5 (Jul 2009) ISSN: 1791-7530 [Electronic] Greece
PMID19596949 (Publication Type: Journal Article)
Topics
  • Genes, BRCA1
  • Genetic Carrier Screening
  • Humans
  • Laryngeal Neoplasms (genetics, pathology)
  • Male
  • Middle Aged
  • Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: